ORAL PRESENTATIONS

Background Core outcome sets (COS) can enhance the relevance of research by ensuring that outcomes of importance to health service users and other people making choices about health care in a particular topic area are measured routinely. Over 200 COS to date have been developed, but the clarity of these reports is suboptimal. COS studies will not achieve their goal if reports of COS are not complete and transparent. Methods and Findings In recognition of these issues, an international group that included experienced COS developers, methodologists, journal editors, potential users of COS (clinical trialists, systematic reviewers, and clinical guideline developers), and patient representatives developed the Core Outcome Set–STAndards for Reporting (COS-STAR) Statement as a reporting guideline for COS studies. The developmental process consisted of an initial reporting item generation stage and a two-round Delphi survey involving nearly 200 participants representing key stakeholder groups, followed by a consensus meeting. The COS-STAR Statement consists of a checklist of 18 items considered essential for transparent and complete reporting in all COS studies. The checklist items focus on the introduction, methods, results, and discussion section of a manuscript describing the development of a particular COS. A limitation of the COS-STAR Statement is that it was developed without representative views of low- and middle-income countries. COS have equal relevance to studies conducted in these areas, and, subsequently, this guideline may need to evolve over time to encompass any additional challenges from developing COS in these areas. Conclusions With many ongoing COS studies underway, the COS-STAR Statement should be a helpful resource to improve the reporting of COS studies for the benefit of all COS users.

Jane M Blazeby | David Moher | Douglas G Altman | Elizabeth Gargon | Paula R Williamson | Mike Clarke | Declan Devane | Peter Tugwell | Jamie J Kirkham | Sean Tunis | R. Bootzin | J. Dorrian | S. Smith | G. Belenky | H. Hiscock | M. Davey | D. Hillman | D. Dawson | M. Knuiman | S. Lockley | S. Rajaratnam | P. Eastwood | K. Maddison | R. Pierce | G. Roach | S. Jay | N. Lamond | S. Ferguson | S. Baulk | P. Rock | J. Kirkness | C. Dakin | R. Grunstein | T. Sletten | P. Catcheside | R. Reed | T. Oei | F. Bashir | P. Swann | J. Walsh | L. Signal | A. Weissenfeld | N. Antic | C. Parsley | D. McEvoy | D. Stadler | D. Bruck | Jochen Schmitt | P. Gander | A. Segal | M. Harris | K. O'Keeffe | S. Cullen | M. Mcmahon | L. Canterford | J. Harris | K. Wong | C. Heuvel | L. Lack | Sarah Gorst | L. Palmer | J. Trinder | A. Peters | C. Chai | G. Paech | A. Esterman | S. Zhu | D. O'Driscoll | G. Nixon | M. Cooper | J. Lee | S. Suresh | M. Ball | L. Simpson | M. Wake | S. Olsen | M. Short | N. Dunn | A. Jackman | S. Hope | V. Anderson | R. Horne | J. Quach | G. Kennedy | M. Howard | J. Redman | N. Marshall | P. Liu | J. Douglas | K. Ward | S. Mukherjee | G. Love | A. Fedson | H. Wright | A. Walker | C. Nicholas | D. Paul | J. Bradley | G. Williams | B. Sweeney | S. Wong | D. Taylor | M. Thomas | J. Hung | A. Vakulin | R. Patterson | A. Foster | J. Yang | E. Hudson | S. Rowland | H. Williams | S. Dunn | J. Potter | M. Ng | M. Horswill | G. Parker | K. Kemp | D. Keenan | J. Veldhuis | M. Muhm | S. Jones | M. Weaver | I. Thomas | S. Garden | H. Gill

[1]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[2]  Douglas G. Altman,et al.  Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey , 2016, PloS one.

[3]  P. Williamson,et al.  Core outcome sets and systematic reviews , 2016, Systematic Reviews.

[4]  Masutaka Furue,et al.  The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. , 2014, The Journal of allergy and clinical immunology.

[5]  D. Moher,et al.  Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.

[6]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[7]  D. Altman,et al.  COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) , 2015, Trials.

[8]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[9]  D. Moher,et al.  CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trialsqqq , 2018 .

[10]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[11]  P. Williamson,et al.  Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people , 2012, Trials.

[12]  S. Leeder,et al.  The asthma health outcome indicators study , 1996, Australian and New Zealand journal of public health.

[13]  Theresa Schilhab,et al.  Issues to Consider , 2017 .

[14]  H. Williams,et al.  The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. , 2015, The Journal of investigative dermatology.

[15]  Jane M Blazeby,et al.  Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.

[16]  Paula R. Williamson,et al.  Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review , 2014, PloS one.

[17]  P. Williamson,et al.  Three nested RCTs of dual or single stakeholder feedback within Delphi surveys during core outcome and information set development , 2015, Trials.

[18]  W. Busse,et al.  Asthma outcomes workshop: overview. , 2012, The Journal of allergy and clinical immunology.

[19]  N. Black CONSORT , 1996, The Lancet.

[20]  P. Williamson,et al.  Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies , 2011, PLoS medicine.